We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.55%
4 Consumer Discretionary 5.99%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REG icon
2501
Regency Centers
REG
$13.9B
-511,302
Closed -$37.3M
REGN icon
2502
Regeneron Pharmaceuticals
REGN
$85.9B
-2,634
Closed -$1.48M
REGN icon
2503
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
-14,000
Closed -$7.87M
RELY icon
2504
Remitly
RELY
$5.65B
-13,401
Closed -$218K
RERE
2505
ATRenew
RERE
$921M
-19,782
Closed -$91K
REZI icon
2506
Resideo Technologies
REZI
$3.08B
-7,639
Closed -$330K
RF icon
2507
Regions Financial
RF
$25.9B
-274,181
Closed -$7.23M
RGEN icon
2508
Repligen
RGEN
$10.2B
-16,331
Closed -$2.18M
RGP icon
2509
Resources Connection
RGP
$149M
-18,309
Closed -$92.5K
RHI icon
2510
Robert Half
RHI
$4.58B
-61,808
Closed -$2.1M
RIVN icon
2511
Rivian
RIVN
$24.6B
-345,896
Closed -$5.08M
RLI icon
2512
RLI Corp
RLI
$6B
-76,509
Closed -$4.99M
RMD icon
2513
ResMed
RMD
$33.4B
-5,806
Closed -$1.59M
ROCK icon
2514
Gibraltar Industries
ROCK
$1.38B
-10,892
Closed -$684K
ROIV icon
2515
Roivant Sciences
ROIV
$26.2B
-178,965
Closed -$2.71M
ROK icon
2516
Rockwell Automation
ROK
$48.5B
-30,555
Closed -$10.7M
RTX icon
2517
RTX Corp
RTX
$283B
-116,880
Closed -$19.6M
RUSHA icon
2518
Rush Enterprises Class A
RUSHA
$8.54B
-16,199
Closed -$866K
RVMD icon
2519
Revolution Medicines
RVMD
$44.9B
-34,575
Closed -$1.61M
RVLV icon
2520
Revolve Group
RVLV
$1.69B
-21,618
Closed -$460K
RVPH
2521
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-2,421
Closed -$17.8K
RWAY icon
2522
Runway Growth Finance
RWAY
$278M
-85,951
Closed -$873K
S icon
2523
SentinelOne
S
$7.26B
-166,068
Closed -$2.92M
SABR icon
2524
Sabre
SABR
$848M
-133,425
Closed -$244K
SAFE
2525
Safehold
SAFE
$1.09B
-55,000
Closed -$852K

Similar funds

Steve Schonfeld's Q4 2025 Portfolio in Review

As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
  • Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.